Picture of Exact Sciences logo

EXAS Exact Sciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Exact Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-596-624-204-1,029-208
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items4552411551,091358
Unusual Items
Other Non-Cash Items
Changes in Working Capital111-26.4-0.342-56122
Change in Accounts Receivable
Change in Inventories
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-102-224156211491
Capital Expenditures-194-214-125-181-210
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-888289174-261405
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,08274.149.7-442195
Financing Cash Flow Items17.82018.613.5-340
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities8.4776.5160232-338
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,176-73367-3.04349